David Hung
Founder at NUVATION BIO INC.
Net worth: 155 M $ as of 2024-04-29
Profile
David T.
Hung was the founder of Medivation, Inc. (founded in 2003) and Medivation LLC (California) (founded in 1995), where he served as President, Chief Executive Officer & Director until 2016.
He is also the founder of Nuvation Bio Operating Co., Inc. (founded in 2018) and Nuvation Bio, Inc. (founded in 2018), where he currently holds the position of President, Chief Executive Officer & Director.
Dr. Hung is also the founder of Repharmation, Inc. Dr. Hung's current jobs include being an Independent Director at NovoCure Ltd.
since 2018, a Director at Establishment Labs SA since 2016, and a Director at Auransa, Inc. Dr. Hung's former jobs include being the President & Chief Executive Officer of Orion Acquisition Corp.
II, President, Chief Executive Officer & Director of Pro-Duct Health, Inc. from 1998 to 2001, President, Chief Executive Officer & Director of Medivation Neurology LLC from 2003 to 2016, Chief Executive Officer & Director of Sio Gene Therapies, Inc. from 2017 to 2018, Chief Executive Officer & Director of Axovant Sciences, Inc. from 2017 to 2018, and an Independent Director at Opexa Therapeutics, Inc. from 2006 to 2011.
Dr. Hung has also held positions as a Director at Agilvax, Inc., Solbec Pharmaceuticals Ltd., NKT Therapeutics, Inc., and Roivant Sciences GmbH.
He was also a VP-Lead Discovery, Development & New Projects at Chiron Corp.
from 1996 to 1998 and a Consultant at Cytyc Health Corp.
from 2001 to 2003.
Dr. Hung's education includes an undergraduate degree from Harvard College and a doctorate from UCSF School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NUVATION BIO, INC. CLASS A
26.73% | 2024-04-14 | 58,281,054 ( 26.73% ) | 153 M $ | 2024-04-29 |
NUVATION BIO, INC.
6.37% | 2024-04-14 | 1,000,000 ( 6.37% ) | 3 M $ | 2024-04-29 |
NOVOCURE LTD.
0.01% | 2024-04-01 | 9,141 ( 0.01% ) | 111 794 $ | 2024-04-29 |
David Hung active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Director/Board Member | 2018-05-30 |
| NUVATION BIO INC. | Founder | 2018-03-19 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Founder | 2017-12-31 |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Director/Board Member | - |
| Repharmation, Inc. | Founder | - |
Establishment Labs SA
 Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Director/Board Member | 2016-01-31 |
Former positions of David Hung
| Companies | Position | End |
|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | Director/Board Member | 2021-02-10 |
| SIO GENE THERAPIES INC. | Chief Executive Officer | 2018-02-11 |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Chief Executive Officer | 2018-01-31 |
| ░░░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of David Hung
| Harvard College | Undergraduate Degree |
| UCSF School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| NUVATION BIO INC. | Health Technology |
| Private companies | 19 |
|---|---|
| Orion Acquisition Corp. II | Finance |
Establishment Labs SA
Establishment Labs SA Medical SpecialtiesHealth Technology Establishment Labs SA is a medical device and aesthetics firm. It designs, develops, manufactures, and ,markets advanced silicon-filled breast and body shaping implants. The company was founded by Juan José Chacon Quiros in 2004 and is headquartered in Alajuela, Costa Rica. | Health Technology |
| Solbec Pharmaceuticals Ltd. | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The company is based in San Francisco, CA. | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
| Cytyc Health Corp. | |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance ARYA Sciences Acquisition Corp. is an organized blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more entities. The company was founded by Joseph Eric Edelman, Adam Stone and Michael Altman in June 2018 and is headquartered in New York, NY. | Finance |
| Repharmation, Inc. | |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Health Technology |
Agilvax, Inc.
 Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
- Stock Market
- Insiders
- David Hung
